Surgery may not improve outcomes in early-stage prostate cancer
A 20-year study found that patients with early-stage prostate cancer who have surgery to remove their tumor do not live longer than those who receive no treatment.
Prostate Cancer
USPSTF recommends individualized approach to prostate cancer screening
The USPSTF recommends that prostate cancer screenings should be an individual decision.
Antiandrogen therapy improves long-term survival after prostate cancer returns
Antiandrogen therapy with daily bicalutamide to salvage radiation therapy resulted in significantly higher rates of long-term overall survival.
Are prostate biopsies linked to the spread of cancerous cells?
Cases of prostate biopsies resulting in the spread of cancerous cells are rare.
Is vasectomy linked to risk of prostate cancer?
Vasectomy can continue to be a safe method of contraception in men.
Risk of Alzheimer dementia after androgen deprivation therapy
A recent cohort study evaluated the risk of developing Alzheimer dementia after ADT in 16,888 men with prostate cancer, 14.2% of whom were treated with ADT.
Diagnostic factors help patients avoid confirmatory prostate biopsy
The analysis of diagnostic characteristics may predict the result of a confirmatory biopsy.
Prostate cancer treatment linked to Alzheimer’s risk
Patients treated with androgen deprivation therapy had a 1.88-times increased rate of developing Alzheimer’s disease.
Active surveillance of low-risk prostate cancer patients may not be efficient
New research suggests that men with low-risk prostate cancer who undergo choose watchful waiting may not receive timely treatment when compared to those undergoing active treatment.
Reduction in number of men screened for and diagnosed with prostate cancer
In the United States, the rate of prostate cancer screening is down, and the number of men diagnosed with the disease has also dropped.
